CEREBRAL VASCULAR DISEASES: THEIR SIGNIFICANCE, DIAGNOSIS AND PRESENT TREATMENT, INCLUDING THE SELECTIVE USE OF ANTICOAGULANT SUBSTANCES

Abstract

Article1 October 1954CEREBRAL VASCULAR DISEASES: THEIR SIGNIFICANCE, DIAGNOSIS AND PRESENT TREATMENT, INCLUDING THE SELECTIVE USE OF ANTICOAGULANT SUBSTANCESIRVING S. WRIGHT, M.D., F.A.C.P., ELLEN MCDEVITT, M.D.IRVING S. WRIGHT, M.D., F.A.C.P., ELLEN MCDEVITT, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-41-4-682 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptCerebral vascular diseases include some of the most serious and widespread of disease processes which still remain among those most neglected. They have been treated too long with a fatalistic philosophy rather than a dynamic one, and no serious attack has been made on the social, economic and personal problems they present.A conference dealing with many aspects of cerebral vascular diseases was recently held in Princeton under the auspices of the American Heart Association and the National Heart Institute, and acknowledgment is herewith made to the participants in the conference for many of the comments contained in this brief...Bibliography1. Kety SS: Transactions of the Conference on Cerebral Vascular Diseases, held at Princeton, New Jersey, January 23-24, 1954, to be published. Google Scholar2. Wright IS: An evaluation of the use of anticoagulant therapy in cardiovascular diseases, Tr. and Stud. Coll. Physicians, Philadelphia, Series 4, 15: 15 (Apr.) 1947. MedlineGoogle Scholar3. WrightMarpleBeck ISCDDF: Report of the Committee for the Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Myocardial Infarction, Am. Heart J. 36: 801-815 (Dec.) 1948. CrossrefMedlineGoogle Scholar4. WrightFoley ISWT: The use of anticoagulants in the treatment of heart disease with special reference to coronary thrombosis, rheumatic heart disease with thromboembolic complications and subacute bacterial endocarditis, Am. J. Med. 3: 718 (Dec.) 1947. CrossrefMedlineGoogle Scholar5. FoleyWright WTIS: Long term anticoagulant therapy for cardiovascular diseases, Am. J. M. Sc. 217: 136 (Feb.) 1949. CrossrefMedlineGoogle Scholar6. FoleyWright WTIS: The treatment of cerebral thrombosis and embolism with anticoagulant drugs: preliminary observations, M. Clin. North America 34: (May) 909-924, 1950. CrossrefMedlineGoogle Scholar7. Cosgriff SW: Prophylaxis of recurrent embolism of intracardiac origin, J. A. M. A. 143: 870, 1950. CrossrefMedlineGoogle Scholar8. AskeyCherry JMCB: Thromboembolism associated with auricular fibrillation. Continuous anticoagulant therapy, J. A. M. A. 144: 97, 1950. CrossrefMedlineGoogle Scholar9. TullochWright JIS: Long term anticoagulant therapy; further experiences, to be published. Google Scholar10. MacMillanBrown RLKW: Haemorrhage in anticoagulant therapy, Canad. M. A. J. 69: 279 (Sept.) 1953. MedlineGoogle Scholar11. WrightMarpleBeck ISCDDF: Myocardial infarction—its clinical manifestations and treatment with anticoagulants. Report of the Committee on Anticoagulants of the American Heart Association, Grune and Stratton, 1954, New York. Google Scholar12. McDevitt E: The use of anticoagulants in the prevention and treatment of cerebral thrombosis and emboli, Transactions of the Conference on Cerebral Vascular Diseases, held at Princeton, New Jersey, January 23-24, 1954, to be published. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New York, N. Y.*Presented as a Morning Lecture before the Thirty-fifth Annual Session of the American College of Physicians, Chicago, Illinois, April 7, 1954.From the Department of Medicine of the Cornell University Medical College and the New York Hospital.Aided by grants from the Kress, Lasker, Hyde and Hampill Foundations, and the U. S. Public Health Service.†By special arrangement this paper will appear simultaneously in The Lancet.‡Acknowledgment is herewith made to the Albert and Mary Lasker Foundation for aid in compilation of the statistics quoted here. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byStroke and t-PA — Triggering New Paradigms of CareStroke: A Modern HistoryAnticoagulant-related hemorrhage in acute cerebral embolism.Transient neurologic deficits associated with congestive heart failure and hypovolemiaAnticoagulant Treatment to Prevent Cerebral InfarctionTreatment of transient ischemic attacks.Treatment of StrokesReversed Vertebral Artery Flow and Cerebral Vascular InsufficiencyJAMES F. TOOLE, M.D., F.A.C.P.Role of anticoagulants in the treatment of cerebrovascular diseaseA Long-term Study of Cerebral Vascular DiseaseSIGMUND N. GROCH, M.D., ELLEN MCDEVITT, M.D., IRVING S. WRIGHT, M.D., F.A.C.P.CORONARY THROMBOSIS, CEREBRAL VASCULAR ACCIDENT AND PULMONARY EMBOLISM IN LEPROSY*JOSEPH H. ROGERS, M.D.The Medical Therapy of Occlusive Cerebrovascular DiseaseMENTAL HEALTH OF THE ELDERLYCEREBRAL EMBOLISMA Cooperative Study of Cerebrovascular DiseaseStrokes; the Present Status of Diagnosis and TreatmentExperience with AnticoagulantsTHE PATHOGENESIS, DIAGNOSIS AND TREATMENT OF STROKES: A PROGRESS REPORT*†IRVING S. WRIGHT, M.D., F.A.C.P.SUPPORTIVE ADRENOCORTICAL STEROID THERAPY IN ACUTE AND SUBACUTE CEREBROVASCULAR ACCIDENTS, WITH PARTICULAR REFERENCE TO BRAIN-STEM INVOLVEMENTINTERMITTENT INSUFFICIENCY OF THE CEREBRAL ARTERIAL CIRCULATIONPAUL W. CLOUGH, M.D.Diagnosis and Current Treatment of StrokesA CRITICAL REVIEW OF CIRCULATORY PHYSIOLOGY AS IT APPLIES TO CEREBRAL VASCULAR DISEASE*PERITZ SCHEINBERG, M.D.Present Status of Anticoagulant Treatment of Cerebral Vascular LesionsLocalized Changes in Properties of the Blood and Effects of Anticoagulant Drugs in Experimental Cerebral InfarctionThe pathogenesis, prevention and medical management of peripheral arterial thrombosisBleeding From Occult Disease During Anticoagulant TherapyTHE SIGNIFICANCE OF NONBACTERIAL THROMBOTIC ENDOCARDITIS: AN AUTOPSY AND CLINICAL STUDY OF 78 CASES*RICHARD A. MACDONALD, M.D., STANLEY L. ROBBINS, M.D.NeurologyThe Use of Anticoagulants: An EvaluationThe Treatment of Cerebrovascular AccidentCurrent Indications for the Use of Anticoagulant Drugs in Cerebrovascular DiseaseRecent Advances in the Investigation and Management of Cerebrovascular DiseasePRESENT STATUS OF ANTICOAGULANT THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION; THE USE AND MISUSE OF ANTICOAGULANTS; AN EVALUATION OF NEW ANTICOAGULANTS, THEIR INDICATIONS AND DOSAGE*IRVING S. WRIGHT, M.D., F.A.C.P.Evaluation of current therapy in cerebral vascular disease 1 October 1954Volume 41, Issue 4Page: 682-698KeywordsAnticoagulantsHeart diseasesHospital medicineMedical servicesVascular diseases ePublished: 1 December 2008 Issue Published: 1 October 1954 PDF downloadLoading ...